Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis.

Kazuhisa ChonabayashiYoshinori YoshidaToshio KitawakiYasuhito NannyaMomoko NakamuraShinichiro OshimaMasakatsu HishizawaKouhei YamashitaSeishi OgawaAkifumi Takaori-Kondo

Published in: Annals of hematology (2019)

Keyphrases

low dose
acute myeloid leukemia
rheumatoid arthritis
high dose
disease activity
allogeneic hematopoietic stem cell transplantation
interstitial lung disease
ankylosing spondylitis
systemic lupus erythematosus
idiopathic pulmonary fibrosis